• BX Home
  • GlaxoSmithKline plc: News

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

GLAXOSMITHKLINE PLC

GlaxoSmithKline plc (GSK) is currently the second-largest pharmaceutical company in the world. Its pharmaceutical segment covers anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. The company produces the popular asthma medicine Advair. GSK’s consumer healthcare segment handles products such as oral healthcare, nutritional drinks, and over the counter medicines. Founded in 1935, GSK’s headquarters are located in Uxbridge, UK.

GlaxoSmithKline plc is part of Business Exchange, suggested by Ulli Muenker. This topic contains 763 news and 87 blog items. Read updated news, blogs, and resources about GlaxoSmithKline plc. Find user-submitted articles and reactions on GlaxoSmithKline plc from like-minded professionals.

News

Recent news on this topic.

The Worst PowerPoint Slide in the Worldmore

Take heart! As bad as your PowerPoint slides are, they are not as bad as what lurks in the U.S. government – the Worst...

New Perspectives and Seven Biotechs for a Diversified Portfolio: Ori H...more

Sometimes speaking with investors who work half a world away is just what's needed to get a new angle and hear new...

Glaxo Promises Growth After 2012 Shortfallmore

GlaxoSmithKline plans to cut costs in its struggling European drugs division and promised investors a return to growth...

GlaxoSmithKline chief apologises after company fined for mis-selling |...more

Britain's biggest pharmaceutical company pledges overhaul after landing record £1.9bn fine in US

Glaxo whistleblowers to share $250m windfallmore

Four former GlaxoSmithKline employees will share up to $250m (£159m) after their evidence helped US authorities secure...

GlaxoSmithKline Agrees to Pay $3 Billion in Fraud Settlementmore

GlaxoSmithKline will plead guilty to promoting two drugs for unapproved uses and to failing to report important safety...

GlaxoSmithKline boss pay packet near doublesmore

GlaxoSmithKline's chief executive saw his earnings almost double last year as total shareholder returns at Britain's...

Conflict of interest fears over vaccine groupmore

Extract not available.

The Missing Link in Innovative Researchmore

R&D organizations have begun to create smaller, more accountable units, but that alone has proven insufficient.

Genetic Technologies Files New Patent Infringement Suit in USAmore

its primary non-coding patent against the following parties: Agilent Technologies Inc.; Bristol-Myers Squibb Company;...

Reportlinker Adds Innovations in Protein Kinase Therapies - Significan...more

5.3.3 Key Indications of Interest 53 5.3.4 First-in-Class and Combination Drugs 54 5.4 GlaxoSmithKline plc 62 5.4.

Cancer Research Grows in Chinamore

Ho, a medical doctor, graduated from Yale University before working in cancer-drug development at Johnson & Johnson...

Anacor Pharmaceuticals Announces Retirement Of Zhi Hong From Board Of ...more

is the Senior Vice President and Head of the Infectious Disease Center of Excellence for Drug Discovery at...

Return of business travel lifts Hogg Robinsonmore

Extract not available.

China���s Cancer Deaths Spur Merck Investment in Beijing Biotechmore

Ho, a medical doctor, graduated from Yale University before working in cancer-drug development at Johnson & Johnson...

Roche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Comingmore

a death sentence, killing 8,700 Americans a year. Now medicines from Roche, Daiichi, Bristol-Myers Squibb Co.

Biotech Calendar: 2011 FDA Drug Approvalsmore

also included. Optimer Pharmaceuticals(OPTR) Drug/indication: Dificid for Clostridium difficile infection FDA approval...

Whistleblower rule clears divided SECmore

has a long history in the United States. Last year the U.S. Department of Justice gave former GlaxoSmithKline Plc...

UPDATE 3-Whistleblower rule clears divided U.S. SECmore

has a long history in the United States. Last year the U.S. Department of Justice gave former GlaxoSmithKline Plc (GSK.

Wes Wheeler Appointed As CEO By Marken's Board Of Directorsmore

Pharmaceuticals International, and has previously held senior executive roles of increasing responsibility in...

Reportlinker Adds Drug Delivery Devices Market Outlook in India to 201...more

categories. Global corporate-level profiles of key companies operating within the India Drug Delivery Devicesmarket.

Reportlinker Adds Drug Delivery Devices Market Outlook in China to 201...more

Global corporate-level profiles of key companies operating within the China Drug Delivery Devices market.

Reportlinker Adds HIV-AIDS Therapeutics - Pipeline Assessment and Mark...more

Analysis of the current and future competition in the global HIV/AIDS therapeutics market. Key market players covered...

AstraZeneca to market Amgen drug with Daiichimore

sold in the U.S. under the brand name Prolia for treating osteoporosis. Amgen and U.K.-based GlaxoSmithKline PLC...

Emerging-Markets Business Offsets Generics: Glaxo CEOmore

GlaxoSmithKline is seeing strong growth from sales in emerging markets, offsetting declines in the U.S.

Top Sources: GlaxoSmithKline plc

  • Financial Times
  • Morningstar.com
  • MarketWatch
  • BusinessWeek
  • TheStreet.com
  • Philadelphia Inquirer
  • Reuters UK
  • Reuters
  • google.com
  • New York Times

Most Active Users in this Topic

see all contributors in GlaxoSmithKline plc

Featured White Papers

Post a Job

Jobs in this Topic

North America (NA) Head, Regulatory Affairs - Vaccines GlaxoSmithKline | Cranberry Township, PA
Posted: Jun 19
Senior Automation Engineer GlaxoSmithKline | Conshohocken, PA
Posted: Jun 15
Production Maintenance Manager GlaxoSmithKline | Memphis, TN
Posted: Jun 10
Manager, Retail Category Solutions / CVS (Boston MA/Providen GlaxoSmithKline | Boston, MA
Posted: Jun 19
Packaging Maintenance Manager GlaxoSmithKline | Memphis, TN
Posted: Jun 10

Report comment contains invalid characters. ()
cancel
Search Cancel